UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

British journal of cancer, 2011-08, Vol.105 (5), p.628-639

2011

Volltextzugriff (PDF)

Identification of serum biomarkers for colon cancer by proteomic analysis

British journal of cancer, 2006-06, Vol.94 (12), p.1898-1905

2006

Volltextzugriff (PDF)

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT‐1 study

British journal of dermatology (1951), 2017-05, Vol.176 (5), p.1148-1154

2017

Volltextzugriff (PDF)

Modelling prognostic factors in advanced pancreatic cancer

British journal of cancer, 2008-09, Vol.99 (6), p.883-893

2008

Volltextzugriff (PDF)

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3188-3194

1999

Volltextzugriff (PDF)

Phase I II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

Gene therapy, 2011-06, Vol.18 (6), p.584-593

2011

Volltextzugriff (PDF)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

British journal of cancer, 2006-01, Vol.94 (2), p.287-292

2006

Volltextzugriff (PDF)

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

Annals of oncology, 2015-12, Vol.26 (12), p.2464-2469

2015

Volltextzugriff (PDF)

The effect of Epstein–Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin’s disease

Annals of oncology, 2003-02, Vol.14 (2), p.282-290

2003

Volltextzugriff (PDF)

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

Annals of oncology, 2001-12, Vol.12 (12), p.1671-1675

2001

Volltextzugriff (PDF)

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

Sarcoma, 2007, Vol.2007, p.13-18

2007

Volltextzugriff (PDF)

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2002-08, Vol.37 (2), p.219-225

2002

Volltextzugriff (PDF)

S88 Day case cisplatin delivery for advanced NSCLC patients: faster, cheaper, more desirable

Thorax, 2011-12, Vol.66 (Suppl 4), p.A42-A42

2011

Volltextzugriff (PDF)

Methodological Considerations in the Evaluation of Radiotherapy Technologies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-12, Vol.24 (10), p.707-709

2012

Volltextzugriff (PDF)

S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC

Thorax, 2011-12, Vol.66 (Suppl 4), p.A41-A41

2011

Volltextzugriff (PDF)

S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes

Thorax, 2011-12, Vol.66 (Suppl 4), p.A41-A42

2011

Volltextzugriff (PDF)

S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients

Thorax, 2011-12, Vol.66 (Suppl 4), p.A41-A41

2011

Volltextzugriff (PDF)

Methods for the analysis of quality-of-life and survival data in health technology assessment

Health technology assessment (Winchester, England), 1999, Vol.3 (10), p.1-152

1999

Volltextzugriff (PDF)

Radiotherapy Research Priorities for the UK

Clinical oncology (Royal College of Radiologists (Great Britain)), 2010-10, Vol.22 (8), p.707-709

2010

Volltextzugriff (PDF)

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

The Lancet (British edition), 2009-02, Vol.373 (9663), p.567-574

2009

Volltextzugriff (PDF)

Quality assurance of CD34+ cell estimation in leucapheresis products

Bone marrow transplantation (Basingstoke), 1996-10, Vol.18 (4), p.791-796

1996

Volltextzugriff (PDF)

Colony counting is a major source of variation in CFU‐GM results between centres

British journal of haematology, 1997-05, Vol.97 (2), p.481-484

1997

Volltextzugriff (PDF)

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

British journal of cancer, 1996-11, Vol.74 (9), p.1487-1491

1996

Volltextzugriff (PDF)

Quality assurance of CFU-GM assays: inter-laboratory variation despite standard reagents

European journal of haematology, 1999-01, Vol.62 (1), p.32-37

1999

Volltextzugriff (PDF)

Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease

Blood, 1999-07, Vol.94 (2), p.442-447

1999

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Identification of serum biomarkers for colon cancer by proteomic analysis

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT‐1 study

Modelling prognostic factors in advanced pancreatic cancer

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

Phase I II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

The effect of Epstein–Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin’s disease

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

S88 Day case cisplatin delivery for advanced NSCLC patients: faster, cheaper, more desirable

Methodological Considerations in the Evaluation of Radiotherapy Technologies

S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC

S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes

S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients

Methods for the analysis of quality-of-life and survival data in health technology assessment

Radiotherapy Research Priorities for the UK

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

Quality assurance of CD34+ cell estimation in leucapheresis products

Colony counting is a major source of variation in CFU‐GM results between centres

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

Quality assurance of CFU-GM assays: inter-laboratory variation despite standard reagents

Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease

Suchergebnisse filtern